ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 324

Regulation of TNF-α-Mediated Activation of Rheumatoid Synovial Fibroblasts By Transcription Factor Snail

Chrong-Reen Wang1,2, Shih-Yao Chen3, Ai-Li Shiau4, I-Ming Jou5,6, Ming-Fei Liu1,2 and Chao-Liang Wu3, 1Internal Medicine, National Cheng Kung University Medical College, Tainan, Taiwan, 2Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, 3Biochemistry and Molecular Biology, National Cheng Kung University Medical College, Tainan, Taiwan, 4Microbiology and Immunology, National Cheng Kung University Medical College, Tainan, Taiwan, 5Orthopedics, National Cheng Kung University Medical College, Tainan, Taiwan, 6Orthopedics, National Cheng Kung University Hospital, Tainan, Taiwan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Animal models, Fibroblasts, rheumatoid arthritis, Rheumatoid arthritis (RA), synovium and transcription factor

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Transcription factor Snail plays active roles in various biological functions and is involved in many disease states. We hypothesized that this molecule regulates TNF-α-mediated activation of rheumatoid synovial fibroblasts (SF), and examined its roles in expression of Cadherin-11 (Cad-11) and α-smooth muscle actin (α-SMA, a myofibroblast marker), invasive ability and IL-6 production.

Methods: Synovial tissues were obtained from patients with rheumatoid arthritis (RA), a diagnosis according to 2010 RA classification criteria, and an experimental arthritis model of collagen-induced arthritis (CIA) in rats. SF were treated with TNF-α or a Wnt signaling inducer, and CIA joints were injected with a TNF-α antagonist. The expression of Snail in SF and joints was modulated by lentiviral vector-mediated transfer of cDNA or short hairpin RNA.

Results: There were higher expression levels of Snail and Cad-11 with a positive correlation in synovial tissues from RA patients and CIA rats. Stimulation with TNF-α or activation of Wnt signaling up-regulated the expression levels of Snail, Cad-11 and α-SMA in SF, and TNF-α antagonist therapy down-regulated their expression levels in CIA joints. While Snail-overexpressed SF transfectants had increased expression levels of Cad-11 and α-SMA and enhanced TNF-α-mediated invasive capacity and IL-6 production, Snail-knockdowned CIASF transfectants had decreased expression levels and the opposite effect on these functions. In addition, Snail-overexpressed normal rat joints had hyperplastic synovium with increased expression levels of Cad-11 and α-SMA. In CIA joints, silencing the expression of Snail ameliorated arthritis with reduced Cad-11 expression and extracellular matrix (ECM) deposition, whereas overexpressing Snail exacerbated arthritis with increased Cad-11 expression and ECM deposition.

Conclusion: This study demonstrates for the first time that transcription factor Snail regulates TNF-α-mediated activation of rheumatoid SF, and these findings might contribute to the pharmacological development of therapeutics targeting SF in RA patients.


Disclosure:

C. R. Wang,
None;

S. Y. Chen,
None;

A. L. Shiau,
None;

I. M. Jou,
None;

M. F. Liu,
None;

C. L. Wu,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulation-of-tnf-%ce%b1-mediated-activation-of-rheumatoid-synovial-fibroblasts-by-transcription-factor-snail/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology